TORONTO, ON–(Marketwired – Aug 16, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), pursuant to its previously announced closing agreement
Easton Pharmaceuticals Announces Finalized Sub-Distribution Agreement With Gedeon Richter S.A.P.I de C.V. For Product Launch Of AmnioSense (AL-Sense)
AmnioSense Represents Second Product Launch With Gedeon Richter, Initial Deposit Received On First Purchase Order With Launch Expected In September
Easton Pharmaceuticals Provides Shareholder Update On Acquisitions, Its Recent MMJ Initiative And Progress On Its Woman’s Diagnostics and Treatment Segment
TORONTO, ON–(Jul 24, 2017) – Easton Pharmaceuticals Inc. (OTC PINK: EAPH) provides shareholder update on new and existing acquisitions including
Easton Pharmaceuticals Announces It Has Received $400,000 USD In Product Purchase Orders For The Current Quarter From Its Woman’s Diagnostic And Treatment Products Business For The Mexico Market
TORONTO, ON–(Marketwired – Jun 26, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH), is pleased to announce it has received an
Easton Pharmaceuticals Announces It Has Finalized Agreement Terms With Alliance Group For Ownership Stake in Several Businesses On 45 Acres Of Agricultural Land, Which Includes The Cultivation of Medical Marijuana For National Canadian Market
Cash Investment Terms Include Guaranteed Revenues Secured With Collateralized Mortgage On Property, Revenues To Commence Within 60 Days TORONTO, ON–(Marketwired
Easton Pharmaceuticals Announces It Has Signed an LOI to Acquire An Interest in a 45 Acre Parcel for the Cultivation of Medical Marijuana in Toronto, Canada; Wholly Owned Subsidiary, iBliss in Birmingham’s UK Vaper Expo
TORONTO, ON–(May 24, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a
Easton Pharmaceuticals Announces Formally Accepting Proposal For The Sub-Licensing Of Product VS-Sense From German based Multi-National Pharmaceutical Company For Mexico; Agreement Includes An Up-Front Cash Payment And a Recurring Royalty
TORONTO, ON–(May 15, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH), announces that Easton / BMV Medica have formally accepted
Easton Pharmaceuticals Announces Signing LOI For The Acquisition Of Revenue Producing, Israel Based Therapeutics Company, Herbs Of Kedem
TORONTO, ON–(May 2, 2017) – Easton Pharmaceuticals, Inc. (OTC: EAPH) announces it has signed an LOI for the acquisition of
Easton Pharmaceuticals Announces Signing NDA and Starts Negotiations For Acquisition
TORONTO, ON–(Apr 24, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce that it has signed a
Easton Pharmaceuticals Announces Signing Of Purchase Agreement Completing The Acquisition Of Revenue Producing Vaporizer and e-Liquids Manufacturer iBliss, Inc.
TORONTO, ON–(Apr 20, 2017) – Easton Pharmaceuticals, Inc. (OTC PINK: EAPH) is pleased to announce the execution of final agreement